Nipah virus infection

A Nipah virus infection is a viral infection caused by the Nipah virus. Symptoms from infection vary from none to fever, cough, headache, shortness of breath, and confusion. This may worsen into a coma over a day or two, and 50 to 75% of those infected die. Complications can include inflammation of the brain and seizures following recovery.[2][1]

Nipah virus infection
Structure of a Henipavirus
SpecialtyInfectious diseases Edit this on Wikidata
SymptomsNone, fever, cough, headache, diarrhea, confusion[1]
ComplicationsInflammation of the brain, seizures[2]
Usual onset5 to 14 days after exposure[1]
CausesNipah virus (spread by direct contact)[1]
Diagnostic methodBased on symptoms, confirmed by laboratory testing[1]
PreventionAvoiding exposure to bats and to sick pigs and people.
TreatmentSupportive care only[2]
PrognosisThe case fatality rate of Nipah virus infection is estimated at 40–75% but can vary by outbreak depending on surveillance and clinical management in affected areas.[3]
Frequency~701 human cases (1998 to May 2018)[4][5]
Deaths~50 to 75% risk of death[4][6]

The Nipah virus (NiV) is a type of RNA virus in the genus Henipavirus, which normally circulates among fruit bats of the genus Pteropus.[7] Spread typically requires direct contact with an infected source; it can both spread between people and from other animals to people. Diagnosis is based on symptoms and confirmed by laboratory testing.[2][1]

Management is restricted to supportive care; as of 2021 there is neither vaccine nor specific treatment.[2] Preventive measures include avoiding exposure to bats and infected animals such as pigs, and not drinking raw date palm sap.[1] As of May 2018 about 700 human cases of Nipah virus were estimated to have occurred, and 50 to 75 percent of those infected died.[4][6][5]

The disease was first identified in 1998 by a team of researchers at the Faculty of Medicine, University of Malaya during an outbreak in Malaysia.[8] The majority of the patients in Malaysia diagnosed with the disease were referred to and treated at the University of Malaya Medical Centre. The virus was isolated and identified in 1999.[2] The disease is named after a village in Malaysia, Sungai Nipah. Pigs may also be infected, and millions were killed by Malaysian authorities in 1999 to stop the spread of disease, a measure which proved to be successful.[2][9]

Signs and symptoms

Human infections range from asymptomatic infection to acute respiratory infection, seizures and fatal encephalitis. This illness typically initially presents as 3-14 days of fever and headache, often accompanied by a cough, sore throat, difficulty breathing, and other signs of respiratory illness.[1] Infected people initially develop symptoms that include fever, headaches, myalgia, vomiting and sore throat. This can be followed by dizziness, drowsiness, altered consciousness, and neurological signs that indicate acute encephalitis. Some people can also experience atypical pneumonia and severe respiratory problems, including acute respiratory distress. Encephalitis and seizures occur in severe cases, progressing to coma within 24 to 48 hours.[1]

The incubation period is from 4 to 14 days but an incubation period as long as 45 days has been reported.[1]

Death occurs in 40-75% of cases, and some long-term side effects of infection include persistent convulsions and personality changes. Most survivors make a full recovery, although some are left with residual neurological conditions after acute encephalitis. Some cases of relapse have been reported.[1]

Transmission

The initial case in human outbreaks of Nipah virus has always been zoonotic[8] from exposure to contaminated secretions or tissues of infected bats or pigs. Subsequent human-to-human transmission of Nipah virus occurs via close contact with NiV-infected persons or exposure to NiV-infected body fluids (e.g., blood, urine, nasal secretions).[1]

Most experts do not classify Nipah virus as airborne, though there is consensus that transmission can—and does—occur from short-range exposure to NiV-infected respiratory droplets in close contact settings.[10]

Indirect transmission of Nipah virus via contaminated fomites is likely responsible for many cases in which there was no known direct contact with a NiV-infected person or animal.[1]

Risk factors

The risk of exposure is high for hospital workers and caretakers of those infected with the virus. In Malaysia and Singapore, Nipah virus infected people with close contact to infected pigs. In Bangladesh and India, the disease has been linked to consumption of raw date palm sap (toddy), eating of fruits partially consumed by bats, and using water from wells inhabited by bats.[11][12]

  • How the Nipah virus spreads
    How the Nipah virus spreads[13]
  • Fruit bats are the natural reservoirs of Nipah virus
    Fruit bats are the natural reservoirs of Nipah virus

Diagnosis
Transmission electron micrograph (TEM) depicted a number of Nipah virus virions from a person's cerebrospinal fluid (CSF).

During acute and convalescent stages of the disease, RNA can be detected using reverse transcriptase polymerase chain reaction (RT-PCR) from throat swabs, cerebrospinal fluid, urine and blood analysis.[1]

After recovery, IgG and IgM antibody detection can confirm a prior Nipah virus infection. Immunohistochemistry on tissues collected during autopsy also confirms the disease.[1]

Prevention

Prevention through sanitary practices is the best protection. The likelihood of infection through animal transmission can be reduced by avoiding exposure to sick pigs, and to bats where the disease is endemic. Bats harbor a significantly higher proportion of zoonotic viruses than all other mammalian orders,[14] and are known not to be affected by the many viruses they carry, apparently due to their developing special immune systems to deal with the stress of flying.[15] Infection via bats can be caused by drinking raw palm sap (palm toddy) contaminated by bat excreta,[16] eating fruits partially consumed by bats, and using water from wells infested by bats.[12] Bats are known to drink toddy that is collected in open containers, and occasionally urinate in it, which contaminates it with the virus;[16] switching to closed-top containers prevents transmission via this route. Outbreaks can be reduced by surveillance and awareness. The association of this disease with the reproductive cycle of bats is not well studied.

Standard infection control practices can protect against human-to-human hospital-acquired infections.[1]

A subunit vaccine using the Hendra G protein was found to produce cross-protective antibodies against both henipavirus and nipahvirus; this has been used in monkeys to protect against Hendra virus, although its potential for use in humans has not been studied.[17]

Treatment

As of 2020, there is no specific treatment for Nipah virus infection.[18] The mainstay of treatment is supportive care. While tentative evidence supports the use of ribavirin, it has not yet been studied in people with the disease.[1] Specific antibodies have also been studied in an animal model with potential benefit.[1] Acyclovir, favipiravir,[18] and remdesivir[19] have been assessed as potential antivirals against Nipah virus.

M 102.4 is a nonpatented monoclonal antibody developed by Christopher C. Broder, a professor of immunology and microbiology at Uniformed Services University of the Health Sciences in Maryland. It proved highly effective in animal models. 50 doses were sent to Kerala in 2018, but it is not clear if they were used in humans.

AChAdOx1 is vector based vaccination which is currently being tested on animals.[20][21][22]

Prognosis

Nipah virus infection is fatal in 40 to 70 percent of cases,[1] though some outbreaks have had 100% case fatality rate.[23]

Sequelae

Those who survive the initial infection often struggle with debilitating long-term neurological sequelae, including memory loss, impaired cognition, seizures, convulsions, and personality changes.[1]

Moreover, Nipah virus is known to be able to persist and lie dormant in survivors and to re-activate many months or years after the initial infection.[1] Deaths from re-activation of latent Nipah virus have been reported.[24]

Outbreaks
Map showing locations of outbreaks of Nipah and Hendra virus as well as the range of Pteropus bats as of 2014

Nipah virus outbreaks have been reported in Malaysia, Singapore, Bangladesh and India. The area is known as the Nipah Belt. The highest mortality due to Nipah virus infection was found in Bangladesh, where outbreaks are typically seen in winter.[25] Nipah virus was first seen in 1998 in peninsular Malaysia in pigs and pig farmers. By mid-1999, more than 265 human cases of encephalitis, including 105 deaths, had been reported in Malaysia, and 11 cases of either encephalitis or respiratory illness with one fatality were reported in Singapore.[26] In 2001, Nipah virus was reported from Meherpur District, Bangladesh[27][28] and Siliguri, India.[27] The outbreak again appeared in 2003, 2004 and 2005 in Naogaon District, Manikganj District, Rajbari District, Faridpur District and Tangail District.[28] In Bangladesh there were further outbreaks in subsequent years.[29][6]

  • September 1998 – May 1999: in the states of Perak, Negeri Sembilan and Selangor in Malaysia. A total of 265 cases of acute encephalitis with 105 deaths caused by the virus were reported in the three states throughout the outbreak.[30] The Malaysian health authorities at first thought Japanese encephalitis (JE) was the cause of infection which hampered the deployment of effective measures to prevent the spread of Nipah virus.[30]
  • 2001: 31 January – 23 February, Siliguri, India: 66 cases with a 74% mortality rate.[31] 75% of patients were either hospital staff or had visited one of the other patients in hospital, indicating person-to-person transmission.
  • 2001: April–May, Meherpur District, Bangladesh: 13 cases with nine fatalities (69% mortality).[32]
  • 2003: January, Naogaon District, Bangladesh: 12 cases with eight fatalities (67% mortality).[32]
  • 2004: January–February, Manikganj and Rajbari districts, Bangladesh: 42 cases with 14 fatalities (33% mortality).
  • 2004: 19 February – 16 April, Faridpur District, Bangladesh: 36 cases with 27 fatalities (75% mortality). 92% of cases involved close contact with at least one other person infected with Nipah virus. Two cases involved a single short exposure to an ill patient, including a rickshaw driver who transported a patient to hospital. In addition, at least six cases involved acute respiratory distress syndrome, which has not been reported previously for Nipah virus illness in humans.
  • 2005: January, Tangail District, Bangladesh: 12 cases with 11 fatalities (92% mortality). The virus was probably contracted from drinking date palm juice contaminated by fruit bat droppings or saliva.[33]
  • 2007: February–May, Nadia District, India: up to 50 suspected cases with 3–5 fatalities. The outbreak site borders the Bangladesh district of Kushtia where eight cases of Nipah virus encephalitis with five fatalities occurred during March and April 2007. This was preceded by an outbreak in Thakurgaon during January and February affecting seven people with three deaths.[34] All three outbreaks showed evidence of person-to-person transmission.
  • 2008: February–March, Manikganj and Rajbari districts, Bangladesh: Nine cases with eight fatalities.[35]
  • 2010: January, Bhanga subdistrict, Faridpur, Bangladesh: Eight cases with seven fatalities. During March, one physician of the Faridpur Medical College Hospital caring for confirmed Nipah cases died.[36]
  • 2011: February: An outbreak of Nipah Virus occurred at Hatibandha, Lalmonirhat, Bangladesh. The deaths of 21 schoolchildren due to Nipah virus infection were recorded on 4 February 2011. IEDCR confirmed the infection was due to this virus.[37] Local schools were closed for one week to prevent the spread of the virus. People were also requested to avoid consumption of uncooked fruits and fruit products. Such foods, contaminated with urine or saliva from infected fruit bats, were the most likely source of this outbreak.[38]
  • 2018: May: Deaths of twenty one[39] people in Perambra near Calicut, Kerala, India were confirmed to be due to the virus. Treatment using antivirals such as Ribavirin was initiated.[40][41]
  • 2019: June: A 23-year-old student was admitted into hospital with Nipah virus infection at Kochi in Kerala.[42] Health Minister of Kerala K. K. Shailaja said that 86 people who had had recent interactions with the patient were under observation. This included two nurses who treated the patient, and had fever and sore throat. The situation was monitored and precautionary steps were taken to control the spread of virus by the Central[43] and State Government.[42] The Health Department of Kerala kept 338 people under observation, 17 of them in isolation. After undergoing treatment for 54 days at a private hospital, the 23-year-old student was discharged. On 23 July, the Kerala government declared Ernakulam district to be Nipah-free.[44]
  • 2021: September: 12-year-old boy, a native of Chathamangalam village was admitted to a hospital at Kozhikode in Kerala on September 1.[45] He died from the virus four days after admission.[46][47][48] Two healthcare workers who came into contact with the victim were already showing symptoms of Nipah infection by Monday.[49]
  • 2023: Since 4 January 2023 and as of 13 February 2023, 11 cases (10 confirmed and one probable) including eight deaths (Case Fatality Rate (CFR) 73%) have been reported in Bangladesh. WHO assesses the ongoing risk as high at the national level.[50]
  • 2023: September: Kozhikode district, Kerala, India: As of 14 September 2023, five cases, including two deaths, were confirmed in Kozhikode district in Kerala. The government has prepared a contact list of over 700 people linked to the two deaths, of whom two family members and a healthcare worker tested positive for the virus.[51][52]

Research

Ribavirin, m102.4 monoclonal antibody, and favipiravir were being studied as treatments as of 2019.[53]

Medication

Ribavirin has been studied in a small number of people. As of 2011, it was unclear whether it was useful, although a few people had returned to normal life after treatment.[54] In vitro studies and animal studies have shown conflicting results in the efficacy of ribavirin against NiV and Hendra, with some studies showing effective inhibition of viral replication in cell lines,[55][56] whereas some studies in animal models showed that ribavirin treatment only delayed but did not prevent death after NiV or Hendra virus infection.[57][58]

In 2013, the anti-malarial drug chloroquine was shown to block the critical functions needed for maturation of Nipah virus, although no clinical benefit was observed.[4]

Immunization

Passive immunization using a human monoclonal antibody, m102.4, that targets the ephrin-B2 and ephrin-B3 receptor-binding domain of the henipavirus Nipah G glycoprotein was evaluated in the ferret model as post-exposure prophylaxis.[4][1] m102.4 has been used in people on a compassionate use basis in Australia, and was in pre-clinical development in 2013.[4]

Society and culture

The fictional MEV-1 virus featured in the 2011 film Contagion was based on a combination of Nipah and measles virus.[59]

A Malayalam movie, Virus, was released in 2019, based on the 2018 outbreak of Nipah virus in Kerala, India.[60][61]

In series 4 episode 1 of The Good Karma Hospital, a patient is admitted with Nipah.

Episode 7 of the Korean drama Doctor John also features a Nipah virus outbreak.

See also

References
  1. "Nipah Virus (NiV)". Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP), Viral Special Pathogens Branch (VSPB). 19 October 2022. Retrieved 17 September 2023.
  2. "Nipah Virus (NiV) Infection". World Health Organization (WHO). Archived from the original on 26 September 2020. Retrieved 14 October 2020.
  3. "Nipah Virus Infection". who.int. World Health Organization. Retrieved 16 February 2023.
  4. Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, et al. (October 2013). "A treatment for and vaccine against the deadly Hendra and Nipah viruses". Antiviral Research. 100 (1): 8–13. doi:10.1016/j.antiviral.2013.06.012. PMC 4418552. PMID 23838047.
  5. "Morbidity and mortality due to Nipah or Nipah-like virus encephalitis in WHO South-East Asia Region, 2001-2018" (PDF). SEAR. Archived from the original (PDF) on 13 June 2018. Retrieved 2 June 2018. 112 cases since Oct 2013
  6. "Nipah virus outbreaks in the WHO South-East Asia Region". South-East Asia Regional Office. WHO. Archived from the original on 23 May 2018. Retrieved 23 May 2018.
  7. Singh, Raj Kumar; Dhama, Kuldeep; Chakraborty, Sandip; Tiwari, Ruchi; Natesan, Senthilkumar; Khandia, Rekha; Munjal, Ashok; Vora, Kranti Suresh; Latheef, Shyma K.; Karthik, Kumaragurubaran; Singh Malik, Yashpal; Singh, Rajendra; Chaicumpa, Wanpen; Mourya, Devendra T. (1 January 2019). "Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review". Veterinary Quarterly. 39 (1): 26–55. doi:10.1080/01652176.2019.1580827. ISSN 0165-2176. PMC 6830995. PMID 31006350.
  8. "Nipah virus factsheet". World Health Organization. 30 May 2018. Retrieved 17 September 2023.
  9. "Seven things you need to know about Nipah virus | Gavi, the Vaccine Alliance". www.gavi.org. 15 September 2023. Retrieved 17 September 2023.
  10. "Nipah virus airborne". Australian Veterinary Journal. 77 (9): 558. 1999. doi:10.1111/j.1751-0813.1999.tb13182.x.
  11. Luby SP, Gurley ES, Hossain MJ (2012). Transmission of Human Infection with Nipah Virus. National Academies Press (US). Archived from the original on 22 May 2018. Retrieved 21 May 2018.
  12. Balan, Sarita (21 May 2018). "6 Nipah virus deaths in Kerala: Bat-infested house well of first victims sealed". The News Minute. Archived from the original on 22 May 2018. Retrieved 21 May 2018.
  13. "Nipah Virus Infection symptoms, causes, treatment, medicine, prevention, diagnosis". myUpchar. Retrieved 27 January 2020.
  14. Olival, Kevin J.; Hosseini, Parviez R.; Zambrana-Torrelio, Carlos; Ross, Noam; Bogich, Tiffany L.; Daszak, Peter (2017). "Host and viral traits predict zoonotic spillover from mammals". Nature. 546 (7660): 646–650. Bibcode:2017Natur.546..646O. doi:10.1038/nature22975. ISSN 0028-0836. PMC 5570460. PMID 28636590.
  15. Huang, Pien (9 February 2020). "Bats Carry Many Viruses. So Why Don't They Get Sick?". National Public Radio (npr).
  16. Islam MS, Sazzad HM, Satter SM, Sultana S, Hossain MJ, Hasan M, et al. (April 2016). "Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011-2014". Emerging Infectious Diseases. 22 (4): 664–70. doi:10.3201/eid2204.151747. PMC 4806957. PMID 26981928.
  17. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, et al. (August 2012). "A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge". Science Translational Medicine. 4 (146): 146ra107. doi:10.1126/scitranslmed.3004241. PMC 3516289. PMID 22875827.
  18. Sharma, V; Kaushik, S; Kumar, R; Yadav, JP; Kaushik, S (January 2019). "Emerging trends of Nipah virus: A review". Reviews in Medical Virology. 29 (1): e2010. doi:10.1002/rmv.2010. PMC 7169151. PMID 30251294.
  19. Lo, Michael K.; Feldmann, Friederike; Gary, Joy M.; Jordan, Robert; Bannister, Roy; Cronin, Jacqueline; Patel, Nishi R.; Klena, John D.; Nichol, Stuart T.; Cihlar, Tomas; Zaki, Sherif R. (29 May 2019). "Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge". Science Translational Medicine. 11 (494): eaau9242. doi:10.1126/scitranslmed.aau9242. ISSN 1946-6234. PMC 6732787. PMID 31142680.
  20. Preetu Nair (26 May 2018). "'Unapproved' drug from Australia to fight Nipah virus? | Kochi News - Times of India". The Times of India. Retrieved 14 September 2021.
  21. Doremalen, Neeltje van; Avanzato, Victoria A.; Feldmann, Friederike; Schulz, Jonathan E.; Haddock, Elaine; Okumura, Atsushi; Lovaglio, Jamie; Hanley, Patrick W.; Cordova, Kathleen; Saturday, Greg; Lambe, Teresa (20 July 2021). "ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys". bioRxiv: 2021.07.20.452991. doi:10.1101/2021.07.20.452991. S2CID 236179976.
  22. NPRFeed (12 September 2021). "Why The World Should Be More Than A Bit Worried About India's Nipah Virus Outbreak". Wisconsin Public Radio. Retrieved 14 September 2021.
  23. Shoemaker, Trevor; Choi, Mary Joung (24 June 2019). "Henipaviruses - Chapter 4 - 2020 Yellow Book | Travelers' Health | CDC". Centers for Disease Control and Prevention. Retrieved 12 December 2021.
  24. "Nipah virus: epidemiology, outbreaks and guidance". Public Health England. 30 May 2018. Retrieved 12 December 2021.
  25. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. (February 2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  26. Eaton BT, Broder CC, Middleton D, Wang LF (January 2006). "Hendra and Nipah viruses: different and dangerous". Nature Reviews. Microbiology. 4 (1): 23–35. doi:10.1038/nrmicro1323. PMC 7097447. PMID 16357858. S2CID 24764543.
  27. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. (February 2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  28. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, et al. (December 2004). "Nipah virus encephalitis reemergence, Bangladesh". Emerging Infectious Diseases. 10 (12): 2082–7. doi:10.3201/eid1012.040701. PMC 3323384. PMID 15663842.
  29. "Basic preventive measures can reduce Nipah virus attack". The Daily Star (Bangladesh). 8 March 2008.
  30. Looi, Lai-Meng; Chua, Kaw-Bing (2007). "Lessons from the Nipah virus outbreak in Malaysia" (PDF). The Malaysian Journal of Pathology. Department of Pathology, University of Malaya and National Public Health Laboratory of the Ministry of Health, Malaysia. 29 (2): 63–7. PMID 19108397. Archived (PDF) from the original on 30 August 2019.
  31. Chadha MS, Comer JA, Lowe L (2006). "Nipah virus-associated encephalitis outbreak, Siliguri, India". Emerging Infectious Diseases. 12 (2): 235–40. doi:10.3201/eid1202.051247. PMC 3373078. PMID 16494748.
  32. Hsu VP, Hossain MJ, Parashar UD (2004). "Nipah virus encephalitis reemergence, Bangladesh". Emerging Infectious Diseases. 10 (12): 2082–7. doi:10.3201/eid1012.040701. PMC 3323384. PMID 15663842.
  33. ICDDR,B (December 2005). "Nipah virus outbreak from date palm juice" (PDF). Centre for Population Research - Health and Science Bulletin. 3 (4): 1–5. ISSN 1729-343X.
  34. "Person-to-person transmission of Nipah infection in Bangladesh" (PDF). Health and Science Bulletin. 5 (4): 1–6. December 2007. ISSN 1729-343X. Archived from the original on 3 February 2009.
  35. ICDDR,B (2008). "Outbreaks of Nipah virus in Rajbari and Manikgonj". Health and Science Bulletin. 6 (1): 12–3. Archived from the original on 3 February 2009.
  36. ICDDR,B (2010). "Nipah outbreak in Faridpur District, Bangladesh, 2010". Health and Science Bulletin. 8 (2): 6–11. Archived from the original on 28 September 2011.
  37. "Arguments in Bahodderhat murder case begin". The Daily Star. 18 March 2008. Retrieved 21 May 2014.
  38. তাহেরকে ফাঁসি দেওয়ার সিদ্ধান্ত নেন জিয়া. prothom-alo.com. 4 February 2011
  39. "Nipah virus outbreak: Death toll rises in Kerala, two more cases confirmed". indianexpress.com. 27 May 2018. Retrieved 29 May 2018.
  40. "Kozhikode on high alert as three deaths attributed to Nipah virus". The Indian Express. 20 May 2018. Retrieved 20 May 2018.
  41. "Deadly Nipah virus claims victims in India". BBC News. 21 May 2018. Retrieved 11 December 2018.
  42. "Kerala Govt Confirms Nipah Virus, 86 Under Observation". New Delhi. 4 June 2019. Archived from the original on 14 July 2019. Retrieved 15 July 2019.
  43. Sharma, Neetu Chandra (4 June 2019). "Centre gears up to contain re-emergence of Nipah virus in Kerala". Mint. Retrieved 7 June 2019.
  44. "Ernakulam district declared Nipah virus free, says Kerala health minister". India Today. Press Trust of India. 23 July 2019.
  45. "Nipah in Kozhikode: Health Minister Veena George says next one week crucial". OnManorama. Retrieved 5 September 2021.
  46. "Nipah returns to Kerala, 12-year-old dead in Kozhikode". The Indian Express. 5 September 2021. Retrieved 5 September 2021.
  47. "Nipah Back to Haunt Kerala as 12-Yr-Old Succumbs to Virus. Symptoms, Treatment & All You Must Know". News18. 5 September 2021. Retrieved 5 September 2021.
  48. Unnithan, P. S. Gopikrishnan (5 September 2021). "12-year-old boy dies of Nipah virus in Kerala's Kozhikode". India Today. Retrieved 5 September 2021.
  49. "Authorities race to contain deadly Nipah virus outbreak in India". www.cbsnews.com. Retrieved 8 September 2021.
  50. "Nipah virus infection - Bangladesh".
  51. Bureau, The Hindu (13 September 2023). "Nipah outbreak | Number of cases rises to 5 in Kerala; 789 contacts kept under watch". The Hindu. ISSN 0971-751X. Retrieved 14 September 2023.
  52. Millson, Alex (14 September 2023). "What Is Nipah and Why Is the Deadly Virus Flaring Up Again". Bloomberg.com. Retrieved 14 September 2023.
  53. Banerjee, S; Gupta, N; Kodan, P; Mittal, A; Ray, Y; Nischal, N; Soneja, M; Biswas, A; Wig, N (February 2019). "Nipah virus disease: A rare and intractable disease". Intractable & Rare Diseases Research. 8 (1): 1–8. doi:10.5582/irdr.2018.01130. PMC 6409114. PMID 30881850.
  54. Vigant F, Lee B (June 2011). "Hendra and nipah infection: pathology, models and potential therapies". Infectious Disorders Drug Targets. 11 (3): 315–36. doi:10.2174/187152611795768097. PMC 3253017. PMID 21488828.
  55. Wright PJ, Crameri G, Eaton BT (March 2005). "RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription". Archives of Virology. 150 (3): 521–32. doi:10.1007/s00705-004-0417-5. PMID 15526144. S2CID 23885676.
  56. Aljofan M, Saubern S, Meyer AG, Marsh G, Meers J, Mungall BA (June 2009). "Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening". Virus Research. 142 (1–2): 92–9. doi:10.1016/j.virusres.2009.01.014. PMC 2744099. PMID 19428741.
  57. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, et al. (May 2006). "Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection". Antimicrobial Agents and Chemotherapy. 50 (5): 1768–72. doi:10.1128/AAC.50.5.1768-1772.2006. PMC 1472238. PMID 16641448.
  58. Freiberg AN, Worthy MN, Lee B, Holbrook MR (March 2010). "Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection". The Journal of General Virology. 91 (Pt 3): 765–72. doi:10.1099/vir.0.017269-0. PMC 2888097. PMID 19889926.
  59. "Nipah virus inspired "Contagion." We're testing a vaccine". www.path.org. Retrieved 17 May 2020.
  60. Virus, retrieved 1 September 2019
  61. "Virus Movie Review {3.5/5}: A well-crafted multi-starrer, fictional documentation on the Nipah virus attack", The Times of India, retrieved 1 September 2019
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.